title: Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.
abstract: To study the role of surface-associated proteins in the virulence of Streptococcus pneumoniae, we used two serotype 3 strains, ATCC 6303 and WU2, and two PspA-negative mutants of WU2, an encapsulated one, JY1123 (Caps(+)/PspA(-)), and an unencapsulated one, DW3.8 (Caps(-)/PspA(-)). ATCC 6303 and WU2 were highly virulent in mice, while the virulence of JY1123 was slightly decreased (50% lethal doses [LD(50)s], 24, 6, and 147 CFU/mouse, respectively); DW3.8 was avirulent (LD(50), 2 x 10(8) CFU). In vitro, ATCC 6303, WU2, and JY1123 (Caps(+)/PspA(-)) strongly resisted complement activation and complement-dependent opsonophagocytosis, whereas DW3.8 (Caps(-)/PspA(-)) was easily phagocytized in fresh serum. Trypsin treatment of ATCC 6303, WU2, and JY1123 (Caps(+)/PspA(-)) resulted in enhanced complement activation and complement-dependent opsonophagocytosis. Trypsin had no deleterious effect on the polysaccharide capsule. In addition, trypsin pretreatment of ATCC 6303 strongly reduced virulence upon intraperitoneal challenge in mice. This indicated that surface proteins play a role in the resistance to complement activation and opsonophagocytosis and contribute to the virulence of type 3 pneumococci. In subsequent experiments, we could show that the modulation of complement activation was associated with surface components that bind complement regulator factor H; binding is trypsin sensitive and independent of prior complement activation. Immunoblotting of cell wall proteins of the virulent strain ATCC 6303 with anti-human factor H antibody revealed three factor H-binding proteins of 88, 150, and 196 kDa. Immunogold electron microscopy showed a close association of factor H-binding components with the outer surface of the cell wall. The role of these factor H-binding surface proteins in the virulence of pneumococci is interesting and warrants further investigation.
authors.affiliation: Eijkman-Winkler Laboratory of Medical Microbiology, The Netherlands.
authors.forename: C
authors.initials: C
authors.lastname: Neeleman
authors.forename: S P
authors.initials: SP
authors.lastname: Geelen
authors.forename: P C
authors.initials: PC
authors.lastname: Aerts
authors.forename: M R
authors.initials: MR
authors.lastname: Daha
authors.forename: T E
authors.initials: TE
authors.lastname: Mollnes
authors.forename: J J
authors.initials: JJ
authors.lastname: Roord
authors.forename: G
authors.initials: G
authors.lastname: Posthuma
authors.forename: H
authors.initials: H
authors.lastname: van Dijk
authors.forename: A
authors.initials: A
authors.lastname: Fleer
mesh_terms: D000818:Animals; D001665:Binding Sites; D002473:Cell Wall; D003167:Complement Activation / Q000276:immunology*; D017242:Complement Factor H / Q000276:immunology*; D006801:Humans; D015151:Immunoblotting; D008297:Male; D051379:Mice; D016253:Microscopy, Immunoelectron; D010587:Phagocytosis / Q000276:immunology*; D013296:Streptococcus pneumoniae / Q000276:immunology* / Q000302:isolation & purification / Q000472:pathogenicity; D014357:Trypsin; D014774:Virulence
chemical_list: C493495:CFH protein, human; D017242:Complement Factor H; D014357:Trypsin